The chimeric Wld^S^ protein (top) protects neurons from degrading after insult, and it needs both its domains to do so.The neuronal guardian protein, Wld^S^, like a true superhero, gained its powers by chance mutation. Now, thanks to two studies, we are closer to understanding how Wld^S^ exerts its protective force.

The slow Wallerian degeneration (Wld^S^) protein and its neuroprotective powers came to exist thanks to a spontaneous mutation that fused the genes for Nmnat1 (a NAD^+^ synthesizing enzyme) and Ube4b (a ubiquitination factor). The mutation was discovered by Coleman et al. in 1998 as the reason why a particular mouse strain, described by Hugh Perry a decade earlier, has exceptionally resistant neurons. Given Wld^S^\'s ability, and thus its therapeutic potential for neurodegenerative diseases, it has become the focus of intense scrutiny.

Two groups, Conforti et al. and Avery et al., have now pulled apart Wld^S^ to learn the secret of its power. They show that both the enzymatic function of Nmnat1 and the ability of the Ube4-derived portion to bind a protein called VCP (or TER94 in flies) are indispensible for Wld^S^\'s neuroprotective effect. VCP is abundant throughout the cell whereas Wld^S^ localizes primarily to the nucleus. However, when Avery et al. expressed mouse Nmnat3---a relative of Nmnat1 with the same enzyme activity, but that in fly neurons fails to localize to the nucleus---it conferred Wld^S^-like protection. Both groups therefore believe that binding of Wld^S^ to VCP localizes Nmnat1 enzyme function to a region of the cytoplasm it wouldn\'t normally encounter. The question now is, where. **RW**
